5 / 19
Page 26
Volume 09
Journal of Alzheimers Disease & Parkinsonism
ISSN: 2161-0460
Epilepsy 2019
Parkinsons Congress 2019
August 29-31, 2019
JOINT EVENT
conferenceseries
.com
August 29-31, 2019 Vienna, Austria
&
5
th
International Conference on
Epilepsy & Treatment
5
th
World Congress on
Parkinsons & Huntington Disease
Epilepsy and neurocutaneous syndromes in developmental age
Michele Roccella
University of Palermo, Italy
Background:
The Neurocutaneous Syndromes (N.S.) are a rarther heterogeneous group of diseases from both a
clinical and genetic point of view. Most N.S. reveal themselves through convulsive crises, wich sometimes do not
respond to the pharmacological treatment. The purpose of this study is to evaluate the therapeutic and clinical
aspects of and adequate therapeutic procedure.
Methods:
78 children have been studied, they are affected by: 33 children from neurofibromatosis; 23 children from
tuberous sclerosis; 9 children from the Sturge-weber syndrome; 5 from Ito hypomelanosis; 4 from incontinentia
pigmenti: | from Dubowitz syndrome; | from the Schimmelpenning-Feuerstin-mims syndrome;! from kippel-
Trenaunay-weber syndrome, 1 from ataxia-telangiectasia. The anamnesis, the hystory of the cris and of the anti-
epileptic therapy was recorder for each case.
Results:
The initial critical symptomatology was divided into groups: infantile spasms; simple focal seizures; focal
focal epilepsy; generalized crises. The age of onset at the beginning of the critical symptomatology is between 15
days and 5 years of age. The neuroradiological pictures observed with brain MRI are fairly heterogeneous. The
evolution and the current state of epileptic symptoms has been evaluated: 40% of cases have generalized epilepsy:
60% of cases a focal epilepsy. The most used drugs are: VPA, CBZ, PB, LTG, BDZ. In some cases cycles of cortisone
therapy (cases with infantile spasms, S. di Lennox-Gastaut) were also practiced. Conclusions: The neurocutaneous
syndromes constitute a group of quite heterogeneous pathologies. The use of tools such as TAC and, above all, MRI
are essential for a correct diagnostic classification. EEG changes are clearly correlated with the type and extent of
the malformation pattern; it seems difficult to establish a specific and pathognomonic picture of a form of S.N.
It remains however difficult to establish, in these pathologies, what is the evolution, the therapeutic strategy to
be implemented and the prognosis of the epileptic symptomatology based on its time of onset and the associated
neuroradiological framework. It is therefore important to underline how the use of new pharmacological therapies
leads to a considerable reduction of critical episodes and consequentially to an improvement in the life of these
subjects. Keywords: Epilepsy, Epilepsy and neurocutaneous syndromes, Antiepileptic drugs Biography Michele
Roccella is Associate Professor of Child Psychiatry at the Department of Psychology, Educational Science and
Human Movement, University of Palermo, Italy. It ’the author of over 450.
Biography
Michele Roccella is Associate Professor of Child Psychiatry at Department of Psychology, Educational Science and Human Movement, University of Palermo,
Italy. Michele Roccella is the author of over 450 publications on National and International Journals.
Michele Roccella, J Alzheimers Dis Parkinsonism 2019, Volume 09